Expression and Clinical Significance of UBE2C in Neuroblastoma

被引：0
作者：
Yuan, X. J. [1 ]
Ma, X. [1 ]
Wang, L. F. [2 ]
机构：
[1] Shanghai Jiao Tong Univ, Paediat Haematol Oncol, Sch Med, Xinhua Hosp, Shanghai, Peoples R China
[2] Shanghai Jiao Tong Univ, Sch Med, Pathol, Xinhua Hosp, Shanghai, Peoples R China
来源：
PEDIATRIC BLOOD & CANCER | 2016年 / 63卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-0556
引用
收藏
页码：S207 / S208
页数：2
相关论文
共 50 条
[41]   Evaluation of the prognostic value of UBE2C mRNA levels in early breast cancer [J].
Psyrri, D. ;
Kronenwett, R. ;
Timotheadou, E. ;
Wirtz, R. M. ;
Onyenadum, A. ;
Pentheroudakis, G. E. ;
Papadimitriou, C. A. ;
Razis, E. ;
Economopoulos, T. ;
Fountzlias, A. .
JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
[42]   UBE2C is a marker of unfavorable prognosis in bladder cancer after radical cystectomy [J].
Morikawa, Teppei ;
Kawai, Taketo ;
Abe, Hiroyuki ;
Kume, Haruki ;
Homma, Yukio ;
Fukayama, Masashi .
INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2013, 6 (07) :1367-1374
[43]   Identification of small molecule inhibitors against UBE2C by using docking studies [J].
Sabitha, Kesavan ;
Rajkumar, Thangarajan .
BIOINFORMATION, 2012, 8 (21) :1047-1058
[44]   UBE2C promotes leptomeningeal dissemination and is a therapeutic target in brain metastatic disease [J].
Paisana, Eunice ;
Cascao, Rita ;
Custodia, Carlos ;
Qin, Nan ;
Picard, Daniel ;
Pauck, David ;
Carvalho, Tania ;
Ruivo, Pedro ;
Barreto, Clara ;
Doutel, Delfim ;
Cabecadas, Jose ;
Roque, Rafael ;
Pimentel, Jose ;
Miguens, Jose ;
Remke, Marc ;
Barata, Joao T. ;
Faria, Claudia C. .
NEURO-ONCOLOGY ADVANCES, 2023, 5 (01)
[45]   UBE2C Is a Transcriptional Target of the Cell Cycle Regulator FOXM1 [J].
Nicolau-Neto, Pedro ;
Palumbo, Antonio, Jr. ;
De Martino, Marco ;
Esposito, Francesco ;
Simio, Tatiana de Almeida ;
Fusco, Alfredo ;
Nasciutti, Luiz Eurico ;
Da Costa, Nathalia Meireles ;
Ribeiro Pinto, Luis Felipe .
GENES, 2018, 9 (04)
[46]   Inhibition of microRNA-17/20a suppresses cell proliferation in gastric cancer by modulating UBE2C expression [J].
Zhang, Yingyi ;
Han, Ting ;
Wei, Guo ;
Wang, Yajie .
ONCOLOGY REPORTS, 2015, 33 (05) :2529-2536
[47]   Validation of a Disease-Free Survival Prediction Model Using UBE2C and Clinical Indicators in Breast Cancer Patients [J].
Shen, Jun ;
Yan, Huanhuan ;
Yang, Congying ;
Lin, Haiyue ;
Li, Fan ;
Zhou, Jun .
BREAST CANCER-TARGETS AND THERAPY, 2023, 15 :295-310
[48]   UBE2C mRNA expression controlled by miR-300 and HuR determines its oncogenic role in gastric cancer [J].
Wang, Ying ;
Huang, Feifei ;
Liu, Ming ;
Zhao, Quan .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 534 :597-603
[49]   Differential Expression of UBE2C and ASCL1 in Neuroendocrine Carcinoma and Adenocarcinoma of the Prostate in Xenograft Models and Human Samples [J].
Tzelepi, V. ;
Maity, S. ;
Zhang, J. ;
Karlou, M. ;
Liang, S. ;
Hoang, A. ;
Lu, J-F ;
Kleb, B. ;
Efstathiou, E. ;
Navone, N. ;
Aparicio, A. ;
Troncoso, P. .
MODERN PATHOLOGY, 2011, 24 :228A-228A
[50]   UBE2C affects breast cancer proliferation through the AKT/mTOR signaling pathway [J].
Lu, Zi-Nan ;
Song, Jia ;
Sun, Tong-Hui ;
Sun, Gang .
CHINESE MEDICAL JOURNAL, 2021, 134 (20) :2465-2474
12345